Molecular profiling of tumours for precision oncology – high hopes <i>versus</i> reality

Sergiusz Nawrocki

doi:10.5114/wo.2018.73873

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Bieżący numer Archiwum Współczesna Onkologia

NOWOŚĆ

Portal dla onkologów!

www.eonkologia.pl

Wyszukiwanie

1/2018

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Artykuł przeglądowy

**Molecular profiling of tumours for precision oncology – high hopes versus reality**

Sergiusz Nawrocki

DOI: https://doi.org/10.5114/wo.2018.73873

Data publikacji online: 2018/03/08

Pełna treść artykułu Pobierz cytowanie

Metryki PlumX:

Treatment based on molecular profiling of tumor is advertised however there are very limited clinical data supporting this approach so far. Only one, relatively small, randomized clinical trial (SHIVA) have not met its primary endpoint - prolongation of PFS. Some other unpublished series were reported during ASCO 2017 and are discussed in this review. There are many issues to be resolved before the tumor profiling will enter the clinical practice with significant benefit for patients, eg. spatial and temporal heterogeneity of tumor cells in individual patient, wide access to targeted therapies, toxicity of combined targeted therapies.